Literature DB >> 30798807

Regulators of hepcidin expression.

Marie-Paule Roth1, Delphine Meynard2, Hélène Coppin2.   

Abstract

Iron, an essential nutrient, is required for many biological processes but is also toxic in excess. The lack of a mechanism to excrete excess iron makes it crucial for the body to regulate the amount of iron absorbed from the diet. This regulation is mediated by the hepatic hormone hepcidin. Hepcidin also controls iron release from macrophages that recycle iron and from hepatocytes that store iron. Hepcidin binds to the only known iron export protein, ferroportin, inducing its internalization and degradation and thus limiting the amount of iron released into the plasma. Important regulators of hepcidin, and therefore of systemic iron homeostasis, include plasma iron concentrations, body iron stores, infection and inflammation, hypoxia and erythropoiesis, and, to a lesser extent, testosterone. Dysregulation of hepcidin production contributes to the pathogenesis of many iron disorders: hepcidin deficiency causes iron overload in hereditary hemochromatosis and non-transfused β-thalassemia, whereas overproduction of hepcidin is associated with iron-restricted anemias seen in patients with chronic inflammatory diseases and inherited iron-refractory iron-deficiency anemia. The present review summarizes our current understanding of the molecular mechanisms and signaling pathways contributing to hepcidin regulation by these factors and highlights the issues that still need clarification.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Erythropoiesis; Hepcidin; Hypoxia; Inflammation; Iron; Testosterone

Mesh:

Substances:

Year:  2019        PMID: 30798807     DOI: 10.1016/bs.vh.2019.01.005

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  13 in total

1.  Editorial: Anemia of Old Age.

Authors:  A M Sanford; J E Morley
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 2.  Insights into basic science: what basic science can teach us about iron homeostasis in trauma patients.

Authors:  Thomas B Bartnikas; Andrea U Steinbicker; Caroline A Enns
Journal:  Curr Opin Anaesthesiol       Date:  2020-04       Impact factor: 2.733

3.  You'd Better Zinc-Trace Element Homeostasis in Infection and Inflammation.

Authors:  Hajo Haase; Lutz Schomburg
Journal:  Nutrients       Date:  2019-09-03       Impact factor: 5.717

4.  Hepcidin Upregulation in Lung Cancer: A Potential Therapeutic Target Associated With Immune Infiltration.

Authors:  Yumei Fan; Bing Liu; Fei Chen; Zhiyuan Song; Bihui Han; Yanxiu Meng; Jiajie Hou; Pengxiu Cao; Yanzhong Chang; Ke Tan
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561

5.  Iron Homeostasis and Hepcidin Concentration in Patients With Acromegaly.

Authors:  Aleksandra Krygier; Ewelina Szczepanek-Parulska; Maja Cieślewicz; Elżbieta Wrotkowska; Justyna Chanaj-Kaczmarek; Marek Ruchała
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-08       Impact factor: 5.555

6.  Expression and Functional Analysis of Hepcidin from Mandarin Fish (Siniperca chuatsi).

Authors:  Yawei Shen; Ziwei Zhao; Jinliang Zhao; Xiaowu Chen; Ming Cao; Minglin Wu
Journal:  Int J Mol Sci       Date:  2019-11-09       Impact factor: 5.923

7.  TGFβ2-Hepcidin Feed-Forward Loop in the Trabecular Meshwork Implicates Iron in Glaucomatous Pathology.

Authors:  Ajay Ashok; Suman Chaudhary; Alexander E Kritikos; Min H Kang; Dallas McDonald; Douglas J Rhee; Neena Singh
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-03-09       Impact factor: 4.799

8.  Protective role of estrogen against excessive erythrocytosis in Monge's disease.

Authors:  Priti Azad; Francisco C Villafuerte; Daniela Bermudez; Gargi Patel; Gabriel G Haddad
Journal:  Exp Mol Med       Date:  2021-01-20       Impact factor: 8.718

Review 9.  Erythrocytes: Central Actors in Multiple Scenes of Atherosclerosis.

Authors:  Chloé Turpin; Aurélie Catan; Olivier Meilhac; Emmanuel Bourdon; François Canonne-Hergaux; Philippe Rondeau
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

Review 10.  Momelotinib: an emerging treatment for myelofibrosis patients with anemia.

Authors:  Helen T Chifotides; Prithviraj Bose; Srdan Verstovsek
Journal:  J Hematol Oncol       Date:  2022-01-19       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.